JP2024521618A5 - - Google Patents

Info

Publication number
JP2024521618A5
JP2024521618A5 JP2023564563A JP2023564563A JP2024521618A5 JP 2024521618 A5 JP2024521618 A5 JP 2024521618A5 JP 2023564563 A JP2023564563 A JP 2023564563A JP 2023564563 A JP2023564563 A JP 2023564563A JP 2024521618 A5 JP2024521618 A5 JP 2024521618A5
Authority
JP
Japan
Application number
JP2023564563A
Other languages
Japanese (ja)
Other versions
JPWO2022223750A5 (https=
JP2024521618A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/060644 external-priority patent/WO2022223750A1/en
Publication of JP2024521618A publication Critical patent/JP2024521618A/ja
Publication of JPWO2022223750A5 publication Critical patent/JPWO2022223750A5/ja
Publication of JP2024521618A5 publication Critical patent/JP2024521618A5/ja
Pending legal-status Critical Current

Links

JP2023564563A 2021-04-23 2022-04-22 複素環式化合物 Pending JP2024521618A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21170090.1 2021-04-23
EP21170090 2021-04-23
CNPCT/CN2022/083125 2022-03-25
CN2022083125 2022-03-25
PCT/EP2022/060644 WO2022223750A1 (en) 2021-04-23 2022-04-22 Heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2024521618A JP2024521618A (ja) 2024-06-04
JPWO2022223750A5 JPWO2022223750A5 (https=) 2025-04-22
JP2024521618A5 true JP2024521618A5 (https=) 2025-04-22

Family

ID=81750728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564563A Pending JP2024521618A (ja) 2021-04-23 2022-04-22 複素環式化合物

Country Status (16)

Country Link
US (1) US20240199587A1 (https=)
EP (1) EP4326714A1 (https=)
JP (1) JP2024521618A (https=)
KR (1) KR20240000574A (https=)
CN (1) CN117295726A (https=)
AR (1) AR125401A1 (https=)
AU (1) AU2022260537A1 (https=)
CA (1) CA3215260A1 (https=)
CL (1) CL2023003154A1 (https=)
CO (1) CO2023014721A2 (https=)
CR (1) CR20230496A (https=)
IL (1) IL306126A (https=)
MX (1) MX2023012477A (https=)
PE (1) PE20240239A1 (https=)
TW (1) TW202309010A (https=)
WO (1) WO2022223750A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2986417T3 (es) 2018-08-13 2024-11-11 Hoffmann La Roche Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa
ES2955037T3 (es) 2018-11-22 2023-11-28 Hoffmann La Roche Nuevos compuestos heterocíclicos
WO2023130043A1 (en) * 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety
WO2023130050A1 (en) * 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain
CA3242372A1 (en) * 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
WO2023144160A1 (en) * 2022-01-25 2023-08-03 F. Hoffmann-La Roche Ag New heterocyclic compounds
JP2025525350A (ja) * 2022-06-24 2025-08-05 エフ. ホフマン-ラ ロシュ アーゲー Magl阻害剤としての新規複素環-カルボニル-環式化合物
CA3261681A1 (en) 2022-08-05 2024-02-08 Kumquat Biosciences Inc. HETEROCYCLIC COMPOUNDS AND THEIR USES
WO2024215863A2 (en) * 2023-04-13 2024-10-17 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
WO2025010392A2 (en) * 2023-07-06 2025-01-09 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment of neurological disorders
WO2025010394A2 (en) * 2023-07-06 2025-01-09 Psy Therapeutics, Inc. Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of inflammatory conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20171057A1 (es) * 2014-10-08 2017-07-21 Hoffmann La Roche Derivados espirodiamina como inhibidores de la aldosterona sintasa
UA125171C2 (uk) * 2015-07-02 2022-01-26 Янссен Саєнсиз Айрленд Юсі Антибактеріальні сполуки
KR102765806B1 (ko) * 2017-09-05 2025-02-10 블랙손 테라퓨틱스, 인크. 바소프레신 수용체 길항제 및 그와 관련된 제품 및 방법
JP2021516229A (ja) * 2018-02-28 2021-07-01 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 低親和性ポリ(ad−リボース)ポリメラーゼ1依存性細胞毒性剤
WO2019209962A1 (en) * 2018-04-25 2019-10-31 Yumanity Therapeutics, Inc. Compounds and uses thereof
ES2955037T3 (es) * 2018-11-22 2023-11-28 Hoffmann La Roche Nuevos compuestos heterocíclicos
CN111793064B (zh) * 2019-04-02 2023-06-23 上海美悦生物科技发展有限公司 一种作为irak抑制剂的化合物及其制备方法和用途
MX2023003240A (es) * 2020-09-22 2023-06-16 Janssen Pharmaceutica Nv Moduladores de monoacilglicerol lipasa de ciclobutilamida.

Similar Documents

Publication Publication Date Title
JP2024521618A5 (https=)
CL2026000218A1 (es) Piperidinadionas sustituidas para la degradación dirigida de proteínas.
CL2022003105A1 (https=)
BR102022025291A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BY13170U (https=)
BY13167U (https=)
CN307049714S (https=)
CN307049371S (https=)
CN307048718S (https=)
CN307046704S (https=)
CN307046413S (https=)
CN307046280S (https=)
CN307045943S (https=)
CN307045474S (https=)
CN307045038S (https=)
CN307044872S (https=)
CN307044271S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13153U (https=)